Geron to Announce Fourth Quarter and Full-Year 2022 Financial Results on March 16, 2023

Rhea-AI Summary

Geron Corporation (Nasdaq: GERN) announced it will release its Q4 and full-year 2022 financial results post-market on March 16, 2023. A conference call will follow at 4:30 p.m. ET to discuss these results and future milestones. The press release will be accessible on their website.

Geron is focused on developing therapies for hematologic malignancies with its investigational telomerase inhibitor, imetelstat, which aims to change the course of these diseases.

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it will release its fourth quarter and full-year 2022 financial results after the market closes on Thursday, March 16, 2023 via press release, which will be available on the Company’s website at www.geron.com/investors. Geron will host a conference call to discuss the financial results as well as upcoming milestones at 4:30 p.m. ET the same day.

A live webcast of the conference call and related presentation will be available on the Company’s website at www.geron.com/investors/events. An archive of the webcast will be available on the Company’s website for 30 days.

Participants may access the webcast by registering online using the following link, https://conferencingportals.com/event/SmvlMvWL.

About Geron

Geron is a late-stage biopharmaceutical company pursuing therapies with the potential to extend and enrich the lives of patients living with hematologic malignancies. Its investigational first-in-class telomerase inhibitor, imetelstat, harnesses Nobel Prize winning science in a treatment that may alter the underlying course of these diseases. To learn more, visit http://www.geron.com/ or follow us on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230309005285/en/

Aron Feingold

Investor and Media Relations

investor@geron.com

media@geron.com

Source: Geron Corporation

FAQ

When will Geron Corporation release its Q4 financial results?

Geron Corporation will release its Q4 financial results on March 16, 2023.

What time will the Geron conference call take place?

The conference call will take place at 4:30 p.m. ET on March 16, 2023.

How can I access the Geron Corporation webcast?

The webcast can be accessed through Geron's website following registration.

What is imetelstat?

Imetelstat is Geron's investigational first-in-class telomerase inhibitor targeting hematologic malignancies.